Alamar Biosciences, Inc.(ALMR)

Biotechnology · Fremont, CA

$38.13+3.77 (+10.97%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

Alamar Biosciences (ALMR) PE Ratio: History & Chart | TGMCharts

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T12:50:25.459Z.

Stored calculation inputs

Calculation as of: 2026-10-06T12:50:25.459Z.

Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 38.13
Unrounded diluted TTM EPS · period ending 2026-06-30: N/A

FMP input reference: 026981202cadb8e73b6cbd63f18abfa8ffa74fea80ac6bbb32512047e0825b9f

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

ALMR PE Ratio Metrics

PE RATIO

N/A

ALMR Competitors' PE Ratio

ALMR

Alamar Biosciences, Inc.

Current

Market Cap

$2.64B

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BEAM

Beam Therapeutics Inc.

vs ALMR

Market Cap

$2.64B

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACHC

Acadia Healthcare Company, Inc.

vs ALMR

Market Cap

$2.69B

PE Ratio

N/A

TTM Avg

12.43

3Y Avg

16.75

5Y Avg

20.41

AVAH

Aveanna Healthcare Holdings Inc.

vs ALMR

Market Cap

$2.69B

PE Ratio

9.79

TTM Avg

24.39

3Y Avg

82.90

5Y Avg

82.90

RXRX

Recursion Pharmaceuticals, Inc.

vs ALMR

Market Cap

$2.51B

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CLOV

Clover Health Investments, Corp.

vs ALMR

Market Cap

$2.43B

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ATRC

AtriCure, Inc.

vs ALMR

Market Cap

$2.87B

PE Ratio

265.65

TTM Avg

234.61

3Y Avg

234.61

5Y Avg

81.83

TMDX

TransMedics Group, Inc.

vs ALMR

Market Cap

$2.87B

PE Ratio

21.50

TTM Avg

33.77

3Y Avg

471.31

5Y Avg

471.31

DYN

Dyne Therapeutics, Inc.

vs ALMR

Market Cap

$2.88B

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ADMA

ADMA Biologics, Inc.

vs ALMR

Market Cap

$2.34B

PE Ratio

14.44

TTM Avg

17.01

3Y Avg

39.38

5Y Avg

39.38

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Alamar Biosciences, Inc. (ALMR)	$2.64B	N/A	N/A	N/A	N/A
Beam Therapeutics Inc. (BEAM)vs ›	$2.64B	N/A	N/A	N/A	N/A
Acadia Healthcare Company, Inc. (ACHC)vs ›	$2.69B	N/A	12.43	16.75	20.41
Aveanna Healthcare Holdings Inc. (AVAH)vs ›	$2.69B	9.79	24.39	82.90	82.90
Recursion Pharmaceuticals, Inc. (RXRX)vs ›	$2.51B	N/A	N/A	N/A	N/A
Clover Health Investments, Corp. (CLOV)vs ›	$2.43B	N/A	N/A	N/A	N/A
AtriCure, Inc. (ATRC)vs ›	$2.87B	265.65	234.61	234.61	81.83
TransMedics Group, Inc. (TMDX)vs ›	$2.87B	21.50	33.77	471.31	471.31
Dyne Therapeutics, Inc. (DYN)vs ›	$2.88B	N/A	N/A	N/A	N/A
ADMA Biologics, Inc. (ADMA)vs ›	$2.34B	14.44	17.01	39.38	39.38

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$38.13

Forward EPS (Est.)

$-1.22

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

ALMR PE Ratio Metrics

ALMR Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics